• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
  • Contact

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Galien Foundation Announces 2016 Prix Galien USA Nominees in "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Medical Technology" Categories

Winners will be Announced and Recognized by World Renown Scientific Committee October 27, 2016 at New York City Prix Galien USA Awards Ceremony


News provided by

The Galien Foundation

Jul 27, 2016, 08:00 ET

Share this article

Share this article


NEW YORK, July 27, 2016 /PRNewswire-USNewswire/ -- The Galien Foundation announced today the 2016 10th Annual Prix Galien USA Award Nominees. The Prix Galien Award is among the health-innovation industry's most prized honors, recognizing biomedical and technology product achievement associated with improving the human condition.  Nominated cutting-edge discoveries hail from laboratories that encompass the world's most innovative biopharma and medical technology companies focusing on major public-health priorities. 

To qualify, each candidate must be U.S. Food and Drug Administration (FDA) approved for market within the last five years and demonstrate tremendous potential to impact human health.  Sales data are not considered by the nominating committee in their award nominee selection; only science and health impact.

"Nominees selected represent the aspirations of biopharmaceutical and medical technology sector scientists to provide for societal health needs," said P. Roy Vagelos, chairman, Prix Galien USA Awards Committee, and prior recipient of the Pro Bono Humanum Award. "The Prix Galien acknowledges innovators whose life-impacting work can save lives and are a platform for future innovation." 

The nominees include in-market products evaluated in the following categories: Best Biotechnology Product – 13 nominees; Best Pharmaceutical Product – 22 nominees, and Best Medical Technology – 11 nominees.

Prix Galien USA 2016 Award Nominees:

Best Biotechnology Product (Nominees)




1.       KANUMA ® (sebelipase alfa)

Alexion Pharmaceuticals, Inc.

2.       STRENSIQ®  (asfotase alfa) 

Alexion Pharmaceuticals, Inc.

3.       IMLYGIC® (talimogene laherparepvec) 

Amgen Inc.

4.       REPATHA® (evolocumab) 

Amgen Inc.

5.       PRAXBIND® (idarucizumab) 

Boehringer Ingelheim

6.       CYRAMZA® (ramucirumab) 

Eli Lilly and Company

7.       TRULICITY® (dulaglutide) 

Eli Lilly and Company

8.       NUCALA® (mepolizumab) 

GlaxoSmithKline plc

9.       DARZALEX® (daratumumab) 

Janssen Biotech, Inc.     

10.     GARDASIL®9 (HPV 9-valent Vaccine, Recombinant) 

Merck & Co., Inc.

11.     COSENTYX® (secukinumab) 

Novartis Pharmaceuticals Corporation

12.     PRALUENT® (alirocumab) 

Regeneron Pharmaceuticals, Inc./Sanofi

13.     NATPARA®  (parathyroid hormone) 

Shire-NPS Pharmaceuticals, Inc.

Best Pharmaceutical Product (Nominees)




1.       DUOPATM (carbidopa/levodopa) 

AbbVie Inc.

2.       TECHNIVIETM (ombitasvir/paritaprevir/ritonavir) 

AbbVie Inc.

3.       UPTRAVI® (selexipag) 

Actelion Pharmaceuticals US, Inc./Nippon Shinyaku Co., Ltd.

4.       KYBELLA® (deoxycholic acid) 

Allergan, Inc.

5.       DALVANCE® (dalbavancin) 

Allergan, Inc.

6.       VIBERZITM (eluxadoline) 

Allergan, Inc.

7.       CRESEMBA® (isavuconazonium sulfate) 

Astellas

8.       TAGRISSOTM (osimertinib) 

AstraZeneca

9.       OFEV® (nintedanib) 

Boehringer Ingelheim

10.     DAKLINZATM (daclatasvir) 

Bristol-Myers Squibb Company

11.     BELVIQ® (lorcaserin HCI) 

Arena Pharmaceuticals, Inc. & Eisai Inc.

12.     HALAVEN® (eribulin mesylate) 

Eisai Inc.

13.     LENVIMA (lenvatinib) 

Eisai Inc.

14.     ALECENSATM (alectinib) 

Genentech, a Member of the Roche Group

15.     AKYNZEO® (netupitant/palonosetron) 

Helsinn Group

16.     VIVLODEX® (SoluMatrix® meloxicam) 

Iroko Pharmaceuticals, LLC

17.     YONDELIS® (trabectedin) 

Janssen Biotech, Inc.

18.     BRIDION® (sugammadex) 

Merck & Co., Inc.  

19.     REXULTI® (brexpiprazole) 

Otsuka Pharmaceutical Company, Ltd./ H. Lundbeck A/S

20.     IBRANCE® (palbociclib) 

Pfizer Inc.

21.     XELJANZ® (tofacitinib citrate) 

Pfizer Inc.

22.     NINLARO® (ixazomib) 

Takeda Pharmaceuticals International Co.  

"Medical technology is a vital addition to the Prix Galien community," notes Bruno Cohen, chairman of the Galien Foundation.  "From cardiovascular disease to imaging to surgical advances and quality of life improvement, technology is playing a larger role in extending quality life.  Prix Galien is proud to evaluate these advances for their health impact."

Best Medical Technology (Nominees)




1.       SpyGlass DS™ Direct Visualization System 

Boston Scientific Corporation                                    

2.       WATCHMAN™ Left Atrial Appendage Closure Device 

Boston Scientific Corporation

3.       Koning Breast CT (CBCT 1000) 

Koning Corporation

4.       CardioMEMS™ HF System 

St. Jude Medical

5.       VITEK® MS 

bioMerieux

6.       Precision Spectra™ Spinal Cord Stimulation (SCS) System 

Boston Scientific Corporation

7.       SAPIEN 3™ Transcatheter Aortic Heart Valve 

Edwards Lifesciences Corporation

8.       Cologuard® 

Exact Sciences Corporation

9.       THERMOCOOL® SMARTTOUCH™ Catheter 

Johnson & Johnson/Biosense Webster

10.     ATTUNE® Knee System 

Johnson & Johnson/DePuy Synthes Companies

11.     EVARREST® Fibrin Sealant Patch 

Johnson & Johnson/Ethicon

The Prix Galien USA Committee is comprised of nine renowned leaders from the biomedical industry and academia, including four Nobel Laureates, responsible for evaluating nominees. Winners will be announced during the Prix Galien USA Awards Ceremony on October 27, 2016, at the American Museum of Natural History in New York City.  Registration to attend the 2016 Prix Galien USA Awards Ceremony can be accessed here.

Galien Awards Committee 2016

Pr Richard Axel, M.D., Nobel Laureate, Co-director, the Kavli Institute for Brain Science, Columbia University Medical Center, New York

Pr Michael S. Brown, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center in Dallas

Pr Laurie Glimcher , M.D., CEO and President, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School

Pr Joseph Goldstein, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center in Dallas

Pr Robert S. Langer, M.D., David H. Koch Institute Professor at MIT

Pr Paul A. Marks, M.D., Laboratory Head  of Cell Biology Memorial Sloan-Kettering Cancer Center, New York , President, Emeritus, MSKCC

Pr Bengt Samuelsson, M.D., Ph.D., Nobel Laureate, Former President of Karolinska Institute and Former Chairman of the Nobel Foundation

Pr Marc Tessier-Lavigne, Ph.D., President and Professor Laboratory of Brain Development and Repair, The Rockefeller University, New York

Pr Roy Vagelos, M.D., Chairman, Prix Galien Committee, Chairman of Regeneron Pharmaceuticals and Retired Chairman and Chief Executive Officer of Merck & Co., Inc.

About the Galien Foundation    

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

The Galien Foundation mourns the loss of its Honorary Member, Pr Elie Wiesel, Peace Nobel Laureate, Boston University Professor Emeritus, who passed away on July 2, 2016.

For more information, visit www.galienfoundation.org.

Galien Foundation Media Contacts:     
Lee Davies/Biopharmaceutical Categories     
Makovsky     
[email protected]                      
212-508-9651     

Kristen Berry/Medical Technology Category     
Finn Partners     
[email protected]    
M: 774-573-0455                                        

SOURCE The Galien Foundation

Related Links

http://www.galienfoundation.org

Modal title

Also from this source

The Galien Foundation Appoints Michael Rosenblatt, M.D., as Chairman of Prix Galien USA Awards Committee

The Galien Foundation Appoints Michael Rosenblatt, M.D., as Chairman of Prix Galien USA Awards Committee


The Galien Foundation Honors 2022 Prix Galien Award Recipients

The Galien Foundation Honors 2022 Prix Galien Award Recipients

Explore

More news releases in similar topics

  • Biotechnology
  • Medical Pharmaceuticals
  • Medical Equipment
  • Pharmaceuticals
  • Health Care & Hospitals

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2023 Cision US Inc.